Real-world pharmacovigilance of thromboembolic adverse events associated with osimertinib using the Japanese adverse drug event report database
Naunyn-Schmiedeberg's Archives of Pharmacology · 19.11.2026
DOI: 10.1007/s00210-026-06097-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 19.11.2026. Verfasst von Yuko Kanbayashi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Evaluation for Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670…. Die Arbeit nennt 28 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Evaluation for Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Himeji Dokkyo University, 7-2-1 Kami-Ohno, Himeji, Hyogo, 670-8524, Japan. ykokanba@gm.himeji-du.ac.jp.
- Department of Pharmacotherapeutics and Pharmacology, School of Pharmacy, Iwate Medical University, 1-1-1 Idaidori, Yahaba, Iwate, 028-3694, Japan.
Zitieren
APA
Kanbayashi, Y., & Hosohata, K. (2026). Real-world pharmacovigilance of thromboembolic adverse events associated with osimertinib using the Japanese adverse drug event report database. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-06097-9
Vancouver
Kanbayashi Y, Hosohata K. Real-world pharmacovigilance of thromboembolic adverse events associated with osimertinib using the Japanese adverse drug event report database. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-06097-9
BibTeX
@article{Kanbayashi2026,
author = {Kanbayashi, Yuko and Hosohata, Keiko},
title = {Real-world pharmacovigilance of thromboembolic adverse events associated with osimertinib using the Japanese adverse drug event report database},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-06097-9}
}
EUVIMED